|Dr. James Timourian Ph.D.||Chairman, CEO, Pres & Sec.||13.5k||N/A||N/A|
|Mr. Alan C. Savage||CFO & Director||N/A||4.25k||1943|
|Dr. Tyler Boone||Chief Operating Officer||N/A||N/A||N/A|
|Dr. Patricia Nadworny||Chief Scientific Officer and Quality & Safety Director||N/A||N/A||N/A|
|Dr. Merle Olson||Scientific Consultant||N/A||N/A||N/A|
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; bacteriophage, cytotoxicity, and in vitro antimicrobial testing; and analytical services. Innovotech Inc. serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company was incorporated in 2001 is headquartered in Edmonton, Canada.
Innovotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.